Form 4: Inari Medical CFO Kevin T. Strange Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Kevin T. Strange, CFO of Inari Medical, reports acquisition of restricted stock units and disposition of shares to cover tax obligations.
Summary
- Kevin T. Strange, the Chief Financial Officer of Inari Medical, Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
- On October 1, 2024, Strange acquired 5,695 restricted stock units (RSUs) with a vesting commencement date of October 1, 2024, where 1/16th of the RSUs vest quarterly.
- On the same day, he disposed of shares to satisfy tax obligations related to vesting RSUs awarded in previous years (2020-2024).
- The prices for the disposed shares were $40.63.
- After these transactions, Strange beneficially owns 47,355 shares of common stock, which includes 5,185 shares acquired through the Employee Stock Purchase Program.
Sentiment
Score: 7
Explanation: The document reflects standard executive compensation practices and insider transactions, suggesting a neutral to slightly positive sentiment as it indicates continued alignment of the CFO with the company's performance.
Positives
- The acquisition of RSUs indicates continued alignment of the CFO's interests with the company's long-term performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the CFO's ongoing equity stake in the company and his participation in equity-based compensation plans.
Comparison to Industry Standards
- Equity compensation is a standard practice for executives in publicly traded companies, particularly in the medical device industry.
- Companies like Medtronic, Boston Scientific, and Abbott also utilize RSUs and stock options as part of their executive compensation packages.
- The vesting schedules and tax implications described in the filing are typical for such arrangements.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation and tax-related stock dispositions.
- Employees participating in the Employee Stock Purchase Program may be interested in the CFO's transactions as a signal of management's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 10/01/2024 | Date of earliest transaction: Acquisition of RSUs and disposition of shares for tax obligations. |
| 10/01/2024 | Vesting commencement date for the acquired RSUs. |
| 10/03/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.